196 related articles for article (PubMed ID: 32109834)
41. Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Buettner S; Amini N; Pawlik TM
J Surg Oncol; 2016 Sep; 114(3):361-7. PubMed ID: 27264476
[TBL] [Abstract][Full Text] [Related]
42. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
43. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.
Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z
Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213
[TBL] [Abstract][Full Text] [Related]
44. Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
Caro-Domínguez P; Gupta AA; Chavhan GB
Pediatr Radiol; 2018 Jan; 48(1):85-93. PubMed ID: 28921384
[TBL] [Abstract][Full Text] [Related]
45. Prediction of hepatic lymph node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection.
Zhu HB; Xu D; Sun XF; Li XT; Zhang XY; Wang K; Xing BC; Sun YS
Cancer Imaging; 2023 Feb; 23(1):18. PubMed ID: 36810192
[TBL] [Abstract][Full Text] [Related]
46. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
[TBL] [Abstract][Full Text] [Related]
47. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
48. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
[TBL] [Abstract][Full Text] [Related]
49. A Whole-Tumor Histogram Analysis of Apparent Diffusion Coefficient Maps for Differentiating Thymic Carcinoma from Lymphoma.
Zhang W; Zhou Y; Xu XQ; Kong LY; Xu H; Yu TF; Shi HB; Feng Q
Korean J Radiol; 2018; 19(2):358-365. PubMed ID: 29520195
[TBL] [Abstract][Full Text] [Related]
50. Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
Allard MA; Saffroy R; de la Maisonneuve PB; Ricca L; Bosselut N; Hamelin J; Lecorche E; Bejarano MA; Innominato P; Sebagh M; Adam R; Morère JF; Lemoine A
Target Oncol; 2015 Sep; 10(3):415-21. PubMed ID: 25420993
[TBL] [Abstract][Full Text] [Related]
51. KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases.
Nash GM; Gimbel M; Shia J; Nathanson DR; Ndubuisi MI; Zeng ZS; Kemeny N; Paty PB
Ann Surg Oncol; 2010 Feb; 17(2):572-8. PubMed ID: 19727962
[TBL] [Abstract][Full Text] [Related]
52. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM
Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041
[TBL] [Abstract][Full Text] [Related]
53. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
[TBL] [Abstract][Full Text] [Related]
54. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
55. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
[TBL] [Abstract][Full Text] [Related]
56. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
57. Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors.
Ingenerf M; Auernhammer C; Lorbeer R; Winkelmann M; Mansournia S; Mansour N; Hesse N; Heinrich K; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2024 Jun; 58(2):196-205. PubMed ID: 38613843
[TBL] [Abstract][Full Text] [Related]
58. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
59. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging?
Wan Q; Deng YS; Lei Q; Bao YY; Wang YZ; Zhou JX; Zou Q; Li XC
Eur Radiol; 2019 Mar; 29(3):1607-1615. PubMed ID: 30255258
[TBL] [Abstract][Full Text] [Related]
60. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]